Arch Therapeutics Inc (ARTH)

[NNW]

When it comes to investing in bio, a wise mentor once told me, "Bad management almost always trumps good science". As the science looks pretty solid, the business acumen at ARTH will become increasingly critical. I like seeing Dr. Norchi with experience at Putnam and an MBA from MIT. MIT is not the easiest school from which to graduate.